HbO

Hemoglobin Oxygen Therapeutics LLC

News

April 18, 2019
Hemopure Plays A Pivotal Role in A Pioneering Study Published in Nature

Researchers from Yale School of Medicine Demonstrated Restored Cellular Functions In Pig Brains After Death Using Hemopure. Hemopure May Become a Novel, Broadly Applicable and Easy-to-Handle Perfusion Solution For Multiple Organs. SOUDERTON, Pa., April 18, 2019 /PRNewswire/ — Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics), a world leader in oxygen-carrying solutions, today announces pioneering research conducted…

April 9, 2019
Hemoglobin Oxygen Therapeutics LLC Announces Preclinical Results on Hemopure in Kidneys Discarded for Human Transplantation

Massachusetts General Hospital Study Suggest that Hemopure is an Acceptable Alternative for Human Blood Products in Kidneys Undergoing Machine Perfusion Technology. Study Published in The American Journal of Transplantation. SOUDERTON, PA, April 9, 2019 /PRNewswire/ — Hemoglobin Oxygen Therapeutics LLC ( HbO2Therapeutics), a biopharmaceutical company specializing in oxygen therapeutics, today announces the publication of preclinical data demonstrating that Hemopure…

February 13, 2019
Hemoglobin Oxygen Therapeutics LLC Announce Updated Results From The Netherlands Leading Liver Transplant Hospital

Pilot study shows ten donor livers previously rejected for transplant, salvaged with new machine perfusion technology using Company’s lead product, Hemopure®. To date, results show 100 percent transplant and survival rates for all patients. SOUDERTON, PA and GRONINGEN, The Netherlands. February 13 2019 —  Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics), a biopharmaceutical company specializing in oxygen…

January 21, 2019
Record number of liver transplants at UMCG due to new perfusion technique

​​In 2018, the UMCG carried out 73 liver transplants. On average around 60 liver transplants were done in the past few years, and in 2017 there were 56. This increase of around 20 percent is almost completely due to the use of normothermic machine preservation of donor livers that were rejected for transplantation in the…

January 16, 2019
The National Institute for Health and Care Excellence (NICE) approves organ perfusion for use on the NHS, stating that perfusion machines could increase the number of livers that can be safely used for transplantation

​A new procedure for storing livers donated for transplant has been hailed a “game changer” and approved for use on the NHS. The National Institute for Health and Care Excellence (NICE) say perfusion machines could increase the number of livers that can be safely used for transplantation. They store donated livers at body temperature, which…

November 8, 2018
Hemopure® to be evaluated in groundbreaking clinical study of trauma patients in the prehospital setting, sponsored by the United States Department of Defense, and coordinated by Stellenbosch University

Patient enrollment expected to commence in mid 2019 Hemopure, the Company’s oxygen carrying solution, could potentially be an integral part of trauma resuscitation practice in remote locations SOUDERTON, Pa., Nov. 8, 2018 /PRNewswire/ — Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics), a private biopharmaceutical company specializing in oxygen therapeutics (previously known as “blood substitutes”) for both…

November 1, 2018
SU awarded contract to direct large clinical study in trauma resuscitation

Patient enrolment expected to commence by mid-2019 and conclude by 2021 Ground-breaking clinical research that has the potential to change pre-hospital care of civilian and military trauma victims worldwide Emergency medicine experts from Stellenbosch University (SU) are embarking on a large, multi-institutional clinical trial in partnership with the United States Department of Defence, to evaluate…

February 16, 2018
Red blood cell substitutes

Nina Notman reports on progress towards products that can, when necessary, replace donor red blood cells